BLOG

Medigene strengthens its DC platform with patent for treatment of stem cell or bone-marrow transplanted patients – Nasdaq

Continue reading

2016-02-23

Medigene strengthens its DC platform with patent for treatment of stem cell or bone-marrow transplanted patients
Nasdaq
For a stem cell or bone-marrow donation without an available HLA-identical “sibling”, healthy relatives of the patient are considered meanwhile as the best potential donors. Those donors are at least HLA haplo-identical with respect to the patient

and more »

Continue reading

2016-02-22

fox13now.com

Stem Cell Joint Regeneration with Intermountain Health & Wellness
fox13now.com
Dr. William Cimikoski, the medical director of Utah Stem Cells Joint Treatment at Intermountain Health and Wellness explained the benefits of stem cell joint regeneration. He answered a few common questions about what he does. Who do these procedures …
MS Stem Cell Therapies Show Promise, But More Work Is Needed, Researcher Tells ACTRIMS 2016Multiple Sclerosis News Today
Stem cell transplant becomes popular option for treatment’Daily Times
Hope, Hype, and Wishful ThinkingUniversity of Rochester Newsroom (blog)

all 4 news articles »

Continue reading

2016-02-22

Whole-Genome Study Allays Cancer Fears Surrounding Stem Cell Techniques
Genetic Engineering & Biotechnology News (blog)
Cell-replacement therapies that depend on induced pluripotent stem cells (iPSCs) inspire hope and fear—hope that cells derived from iPSCs will actualize regenerative medicine; fear that the very same cells will bring cancer-causing mutations to patients.
Popular Stem Cell Techniques Safe From Cancer-Causing Mutatations, Study SaysHeadlines & Global News
Scientists Find Popular Stem Cell Techniques SafeLab Manager | News (press release) (blog)

all 4 news articles »

Continue reading

2016-02-22

Multiple Sclerosis News Today

MS Stem Cell Therapies Show Promise, But More Work Is Needed, Researcher Tells ACTRIMS 2016
Multiple Sclerosis News Today
Dr. Goodman, a professor of Neurology, chief of the Neuroimmunology Unit, and director of the Multiple Sclerosis Center at the university, reviewed current stem cell therapy approaches, including the use of “hematopoietic stem cell reconstitution
Stem cell transplant becomes popular option for treatment’Daily Times
Hope, Hype, and Wishful ThinkingUniversity of Rochester Newsroom (blog)

all 3 news articles »